Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies
- PMID: 24646010
- PMCID: PMC4239967
- DOI: 10.1111/bcp.12383
Antidepressant use and risk of coronary heart disease: meta-analysis of observational studies
Abstract
Aims: Our goal was to evaluate the association between antidepressant use and the risk of coronary heart disease (CHD) among subjects with no history of coronary heart disease.
Methods: A search of Medline, EMBASE, PsycINFO and the Cochrane Library was performed in January 2013. Two authors independently reviewed and selected eligible observational studies, based on predetermined selection criteria. Pooled relative risks (RRs) with confidence intervals (CIs) were calculated using random-effects or fixed-effects models.
Results: Sixteen observational studies (seven case-control studies and nine cohort studies) were included in the final analysis. There was no association between selective serotonin reuptake inhibitor use and the risk of CHD overall [odds ratio (OR), 0.93; 95% CI, 0.65-1.33] or in subgroup meta-analysis of case-control studies (OR, 0.91; 95% CI, 0.60-1.37) and cohort studies (RR, 0.96; 95% CI, 0.59-1.55). The use of tricyclic antidepressant was associated with an increased risk of CHD overall (OR, 1.51; 95% CI, 1.07-2.12), but it was observed only in case-control studies (OR, 1.56; 95% CI, 1.24-1.96) and low-quality studies (OR, 1.49; 95% CI, 1.20-1.85) in the subgroup meta-analyses.
Conclusions: This meta-analysis of observational studies in subjects with no history of CHD suggests that neither selective serotonin reuptake inhibitor nor tricyclic antidepressant use is associated with an increased risk of CHD.
Keywords: antidepressant; coronary heart disease; meta-analysis; myocardial infarction; selective serotonin reuptake inhibitor; tricyclic antidepressant.
© 2014 The British Pharmacological Society.
Figures



Similar articles
-
Antidepressant use and the risk of seizure: a meta-analysis of observational studies.Eur J Clin Pharmacol. 2024 Feb;80(2):175-183. doi: 10.1007/s00228-023-03597-y. Epub 2023 Nov 24. Eur J Clin Pharmacol. 2024. PMID: 37996536 Review.
-
A Systematic Review and Meta-Analysis Considering the Risk for Congenital Heart Defects of Antidepressant Classes and Individual Antidepressants.Drug Saf. 2021 Mar;44(3):291-312. doi: 10.1007/s40264-020-01027-x. Epub 2020 Dec 22. Drug Saf. 2021. PMID: 33354752
-
Association between antidepressant medication use and epithelial ovarian cancer risk: a systematic review and meta-analysis of observational studies.Br J Clin Pharmacol. 2018 Apr;84(4):649-658. doi: 10.1111/bcp.13498. Epub 2018 Feb 5. Br J Clin Pharmacol. 2018. PMID: 29292523 Free PMC article.
-
WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).Cochrane Database Syst Rev. 2007 Jul 18;(3):CD002791. doi: 10.1002/14651858.CD002791.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636706 Review.
-
Impact of antidepressants use on risk of myocardial infarction: A systematic review and meta-analysis.Indian J Pharmacol. 2015 May-Jun;47(3):256-62. doi: 10.4103/0253-7613.157112. Indian J Pharmacol. 2015. PMID: 26069361 Free PMC article. Review.
Cited by
-
General practice management of depression among patients with coronary heart disease in Australia.BMC Prim Care. 2022 Dec 16;23(1):329. doi: 10.1186/s12875-022-01938-x. BMC Prim Care. 2022. PMID: 36526976 Free PMC article.
-
Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database.BMJ. 2016 Mar 22;352:i1350. doi: 10.1136/bmj.i1350. BMJ. 2016. PMID: 27005565 Free PMC article.
-
The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular Diseases.CNS Drugs. 2020 Nov;34(11):1133-1147. doi: 10.1007/s40263-020-00763-z. CNS Drugs. 2020. PMID: 33064291 Free PMC article. Review.
-
Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis.Br J Clin Pharmacol. 2016 Sep;82(3):624-32. doi: 10.1111/bcp.12985. Epub 2016 May 23. Br J Clin Pharmacol. 2016. PMID: 27198162 Free PMC article. Review.
-
Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies.Eur J Clin Pharmacol. 2017 Apr;73(4):487-497. doi: 10.1007/s00228-016-2187-x. Epub 2017 Jan 9. Eur J Clin Pharmacol. 2017. PMID: 28070601
References
-
- Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66:848–856. - PubMed
-
- Reid S, Barbui C. Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants. BMJ. 2010;340:c1468. - PubMed
-
- Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000;108:2–8. - PubMed
-
- Lapane KL, Zierler S, Lasater TM, Barbour MM, Carleton R, Hume AL. Is the use of psychotropic drugs associated with increased risk of ischemic heart disease? Epidemiology. 1995;6:376–381. - PubMed
-
- Penttinen J, Valonen P. Use of psychotropic drugs and risk of myocardial infarction: a case-control study in Finnish farmers. Int J Epidemiol. 1996;25:760–762. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical